$ENOV Balance Sheet | Understand Stock

$ENOV

$21.54 +$0.38 (1.8%) Close

$ENOV Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jul 3, 2026	Q1 FY2026 As of Apr 3, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Oct 3, 2025	Q2 FY2025 As of Jul 4, 2025	Q1 FY2025 As of Apr 4, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 27, 2024	Q2 FY2024 As of Jun 28, 2024	Q1 FY2024 As of Mar 29, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 29, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jul 1, 2022	Q1 FY2022 As of Apr 1, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Oct 1, 2021
ASSETS
Cash and cash equivalents
Trade receivable, less allowance for credit losses
Inventories, net
Prepaid expenses
Other current assets
Investment in ESAB Corporation
Total current assets associated with discontinued operations
Current portion of assets held for sale
Total current assets
Property, plant and equipment, net
Goodwill
Intangible assets, net
Lease asset - right of use
Other assets
Total non-current assets associated with discontinued operations
Total assets

LIABILITIES AND EQUITY
Current portion of long-term debt
Accounts payable
Accrued liabilities
Current portion of liabilities held for sale
Total current liabilities
Long-term debt, less current portion
Non-current lease liability
Other liabilities
Total non-current liabilities associated with discontinued operations
Total liabilities
Common Stock, Shares, Outstanding
Equity:
Common stock, $0.001 par value; 133,333,333 shares authorized; 57,665,074 and 57,194,781 shares issued and outstanding as of July 3, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total Enovis Corporation equity
Noncontrolling interest
Total equity
Total liabilities and equity

Comments